Late Stage Investors & VC Firms in North America
1701 firms in this list, with a median first check of $1M. 371 of them lead rounds. Generated from verified public data and updated continuously.
Disruptive Ventures
New YorkSeed–Late Stage
3 people
Novalis LifeSciences
PortsmouthSeed–Late Stage
9 people
NW Angel
SeattlePre-Seed–Late Stage
3 people
Portal Ventures
AustinSeed–Late Stage$1M – $10M
3 people
Iconica Partners
Silicon ValleySeed–Late Stage
4 people
Legendary Ventures, Llc.
New York CitySeed–Late Stage
9 people
La Caisse
MontréalGrowth–Late Stage
2 people
Aspen Capital Group
Growth–Late Stage$5M – $20M
4 people
CerraCap Ventures
Costa MesaSeed–Late Stage
7 people
GPO Fund
New YorkSeries A–Late Stage$5M – $10M
4 people
Massachusetts Capital Resource Co.
BostonGrowth–Late Stage$1M – $5M
4 people
Biotechnology Value Fund
San FranciscoLate Stage
3 people
Core Capital Partners
PotomacSeed–Late Stage$250K – $2M
12 people
Mauloa
PotomacGrowth–Late Stage$10M – $30M
6 people
Supply Chain Ventures
BostonSeed–Late Stage
6 people
What If Ventures
FriscoPre-Seed–Late Stage
3 people
Sequel Venture Partners
BoulderPre-Seed–Late Stage
8 people
Treo Ventures, Llc
MinneapolisSeed–Late Stage
5 people
Harmonic Growth Partners
Chevy ChaseSeries B–Late Stage
2 people
XPV Water Partners
TorontoSeries A–Late Stage
2 people
Asia Alternatives Management
San FranciscoSeed–Late Stage
9 people
ICONIQ Capital
San FranciscoSeed–Late Stage$5M – $100M
VIATEC
VictoriaPre-Seed–Late Stage
9 people
Brand Capital International
Redwood CitySeed–Late Stage
8 people
Related lists
Investors & VC Firms in North America (13845)Investors & VC Firms in United States (12980)Seed Investors & VC Firms (10975)Series A Investors & VC Firms (8160)Pre-Seed Investors & VC Firms (5955)Seed Investors & VC Firms in North America (5705)Investors & VC Firms in Europe (5528)Seed Investors & VC Firms in United States (5128)Growth Investors & VC Firms (4870)Series A Investors & VC Firms in North America (4605)
Data sourced from public filings and firms' own websites — see our methodology.































































